Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Authors:
Emery P, Van Keep M, Beard S, Graham C, Miles L, Jugl SM, Gunda P, Halliday A, Marzo-Ortega H
Publication type:
Journal article
Publication name:
Pharmacoeconomics
Citation:
Emery P, Van Keep M, Beard S, Graham C, Miles L, Jugl SM, Gunda P, Halliday A and Marzo-Ortega H. Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK. Pharmacoeconomics. 2018; 36(8):1015-27.
